These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Attenuation of mTOR Signaling Is the Major Response Element in the Rescue Pathway of Chronic Kidney Disease in Rats. Wang J; Chai L; Lu Y; Lu H; Liu Y; Zhang Y Neuroimmunomodulation; 2020; 27(1):9-18. PubMed ID: 32526762 [TBL] [Abstract][Full Text] [Related]
12. AKT2 is essential to maintain podocyte viability and function during chronic kidney disease. Canaud G; Bienaimé F; Viau A; Treins C; Baron W; Nguyen C; Burtin M; Berissi S; Giannakakis K; Muda AO; Zschiedrich S; Huber TB; Friedlander G; Legendre C; Pontoglio M; Pende M; Terzi F Nat Med; 2013 Oct; 19(10):1288-96. PubMed ID: 24056770 [TBL] [Abstract][Full Text] [Related]
13. [Chronic renal insufficiency: 1) adaptation of nephron function in chronic renal insufficiency and 2) progression of chronic renal insufficiency]. Savin M Srp Arh Celok Lek; 1998; 126(7-8):261-70. PubMed ID: 9863393 [TBL] [Abstract][Full Text] [Related]
14. Chronic Kidney Disease and Exposure to Nephrotoxic Metals. Orr SE; Bridges CC Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28498320 [TBL] [Abstract][Full Text] [Related]
15. Nephron number, hypertension, and CKD: physiological and genetic insight from humans and animal models. Wang X; Garrett MR Physiol Genomics; 2017 Mar; 49(3):180-192. PubMed ID: 28130427 [TBL] [Abstract][Full Text] [Related]
16. Nephrons, podocytes and chronic kidney disease: Strategic antihypertensive therapy for renoprotection. Haruhara K; Kanzaki G; Tsuboi N Hypertens Res; 2023 Feb; 46(2):299-310. PubMed ID: 36224286 [TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide Induces Chronic Kidney Injury and Fibrosis through Activation of mTOR Signaling in Macrophages. Chen H; Zhu J; Liu Y; Dong Z; Liu H; Liu Y; Zhou X; Liu F; Chen G Am J Nephrol; 2015; 42(4):305-17. PubMed ID: 26517816 [TBL] [Abstract][Full Text] [Related]